Immunology is at the heart of advances in cancer which are exciting researchers, clinicians and patients alike. After decades of painstaking research which delivered few practical benefits, new agents are proving effective even in hard-to-treat and solid cancers. Immunotherapy is becoming a powerful new tool.
The EJC Immunology in Cancer Resource Centre will host original articles, expert commentaries and interviews. It will cover new therapies and combinations – plus the implications for clinical practice – and will keep you abreast of developments in this fast-moving field.
Latest Articles on Immunotherapy
Suzanne L Topalian, Charles G Drake, Drew M Pardoll
Current Opinion in Immunology, 2, 24, pages 207 - 212
Drug of the year: Programmed Death-1 receptor/Programmed Death-1 Ligand-1 receptor monoclonal antibodies
Caroline Robert, Jean-Charles Soria, Alexander M.M. Eggermont
European Journal of Cancer, 14, 49, pages 2968 - 2971
Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancer
Kazuhiro Kakimi, Jun Nakajima, Hiromi Wada
Lung Cancer, 1, 65, pages 1 - 8